# Cancer Research UK

> Cancer Research UK is a VC fund backing Health Care and Biotechnology. See 5 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: London, United Kingdom
- Total investments: 5
- Last investment: Dec 2025
- Lead investor: 40%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/CR_UK
- Website: http://www.cancerresearchuk.org
- Facebook: https://www.facebook.com/cancerresearchuk

Cancer Research UK is a VC fund in London focused on Health Care and Biotechnology. Cancer Research UK pioneers life-saving research to bring forward the day when all cancers are cured.

## Contacts

5 contacts available for Cancer Research UK. Shizune tracks 6 team members at Cancer Research UK. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/cancer-research-uk?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 3 | 60% |
| Biotechnology | 3 | 60% |
| Medical | 1 | 20% |
| Therapeutics | 1 | 20% |
| Health Diagnostics | 1 | 20% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Grant | 3 | 60% |
| Seed | 2 | 40% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 3 | 60% |
| Singapore | 1 | 20% |
| The Netherlands | 1 | 20% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Avin Talabani | Emerging Technology Exploration Lead | 0 | — |
| James Ritchie | Drug Development Strategy Lead | 0 | — |
| Philip Almond | Executive Director Fundraising & Marketing | 0 | — |
| Dmitry Soloviev | Senior PET chemist, Beatson Institute | 0 | — |
| Nick Jame | Co-Founder | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Laigo Bio | Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders. | $13.4M | Seed | Dec 03, 2025 |  |
| University of the West of Scotland | University of the West of Scotland is a school. |  | Grant | Mar 21, 2023 |  |
| North East Innovation Lab | North East Innovation Lab is part of Newcastle Hospitals that helps hospitals in development of new diagnostics. | $265.4K | Grant | Jul 28, 2022 |  |
| OxCan | OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $1.8M | Seed | Sep 06, 2021 |  |
| Sengenics | Sengenics is a functional proteomics company that leverages its patented KREX™ technology for production of full-length, correctly folded and functional proteins. KREX™ was invented and patented by Professor Jonathan Blackburn whilst he was a member of the faculty at the University of Cambridge. Jonathan is the CSO of Sengenics.The keyapplication of KREX™ is the discovery of autoantibody biomarkers for two core medical use cases. Firstly, stratification of patients undergoing treatment with autoimmune or cancer drugs into responders, non-responders and those that may exhibit severe immune-related adverse events. Secondly, identification of autoantibody biomarkers that may be used to diagnose cancer, autoimmune or neurodegenerative conditions years before conventional diagnostic tests. |  | Grant | Nov 26, 2019 |  |

5 of 5 investments shown.

## Co-investors
- [Angelini Ventures](https://shizune.co/investors/profile/angelini-ventures) — VC Fund, 1 deal together
- [ARGOBIO](https://shizune.co/investors/profile/argobio) — VC Fund, 1 deal together
- [Cancer Research Horizons](https://shizune.co/investors/profile/cancer-research-technology) — VC Fund, 1 deal together
- [Civilization Ventures](https://shizune.co/investors/profile/civilization-ventures) — VC Fund, 1 deal together
- [Curie Capital](https://shizune.co/investors/profile/curie-capital) — VC Fund, 1 deal together
- Engineering and Physical Sciences Research Council — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Scottish Enterprise](https://shizune.co/investors/profile/scottish-enterprise) — VC Fund
- [Foundation for Innovation and Technology (FIT)](https://shizune.co/investors/profile/foundation-pour-l-innovation-technologique) — VC Fund
- [Business Finland](https://shizune.co/investors/profile/tekes) — VC Fund

## FAQ

### What does Cancer Research UK invest in?

Cancer Research UK invests primarily in Health Care, Biotechnology and Medical startups, most often at Grant and Seed stage. Most of the 5 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Cancer Research UK?

Public channels for Cancer Research UK include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Cancer Research UK?

The team at Cancer Research UK includes Avin Talabani (Emerging Technology Exploration Lead), James Ritchie (Drug Development Strategy Lead) and Philip Almond (Executive Director Fundraising & Marketing), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co